An article published by Merlin researchers from UNIPD has recently been published in the “Leukemia” journal. The piece is entitled “Mouse mesenchymal stem cells inhibit high endothelial cell activation and lymphocyte homing to lymph nodes by releasing TIMP-1” (Author(s): Zanotti L, Angioni R, Calì B, Soldani C, Ploia C, Moalli F, Gargesha M, D’Amico G, Elliman S, Tedeschi G, Maffioli E, Negri A, Zacchigna S, Sarukhan A, Stein JV, Viola A) and appears in the May issue. The article deals with the impact of MSC on immunity and inflammation and identifies TIMP-1 as a novel biomarker for MSC-based therapy. You can access the article here.
- Interesting read: Development, functional characterization, validation of phagocytic macrophages for liver cirrhosis t.co/5C5pQwXQns Time ago 2 Days via Hootsuite
- RT @EUSciComm: The EU Guide to Science Communication: Communicating Science — things to remember t.co/DEE2d878SZ … #SciCo… https:/… Time ago 2 Days via Hootsuite
- RT @EU_Health: #PublicConsultation Evaluation of the EU #blood and #tissues and #cells legislation. Deadline: 31.08.2017 t.co/wft9J… Time ago 2 Days via Hootsuite
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.